Patent ID: 11965218
Assignee: YALE UNIVERSITY
Field: Measurement (Instruments)
Classification: CPC C  G | IPC C  G

Claim 2:
3. The method of claim 1, wherein the at least one nasal virus-induced molecule is interferon-induced protein with tetratricopeptide repeats (IFIT) 1 (IFIT1), IFIT2, IFIT3, 2′-5′ oligoadenylate synthetase-like (OASL), 2′-5′ oligoadenylate synthetase (OAS) 1 (OAS1), OAS2, OAS3, interferon-stimulated gene 15 (ISG15), interferon induced with helicase C domain 1 (IFIH1), interferon induced protein 44 (IFI44), DExD/H-box helicase (DDX) 58 (DDX58), DDX60, DDX60-like (DDX60L), HECT and RLD domain containing E3 ubiquitin protein ligase 5 (HERC5), myxovirus resistance (MX) 1 (MX1), MX2, interferon induced transmembrane protein 1 (IFITM1), radical S-adenosyl methionine domain containing 2 (RSAD2), IFI44-like (IFI44L), interferon alpha inducible protein 27 (IFI27), DExH-box helicase 58 (DHX58), C—X—C motif chemokine ligand (CXCL) 10 (CXCL10), C—X3-C motif chemokine ligand 1 (CX3CL1), CXCL8, CXCL11, CXCL1, interleukin 36 gamma (IL36G), CXCL9, interferon lambda 2 (IFNL2), CXCL2, tumor necrosis factor (TNF), CXCL3, or C—C motif chemokine ligand 22 (CCL22).